Abrexa Pharmaceuticals

United States
Wonewoc, Wisconsin, United States, 92103-5128

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$39.6M
Last funding
Series B / $23M / 2025-04-24
Last equity funding
Series B / $23M
Founders
1

Founders and investors

Founders

Eckard Weber